Vijaypd Ceutical Ltd. IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| NII (HNI) | — | 2,608,000 (47%) | — | ₹913 Cr |
| Retail | — | 2,608,000 (47%) | — | ₹913 Cr |
| Market Maker | — | 284,000 (5%) | — | ₹10 Cr |
| Σ Total | — | 5,500,000 (100%) | — | ₹19,250 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 4,000 | ₹140,000 |
| Retail (Max) | 13 | 52,000 | ₹1,820,000 |
| S-HNI (Min) | 14 | 56,000 | ₹1,960,000 |
| B-HNI (Min) | 67 | 268,000 | ₹9,380,000 |
Financial Statements Amount in ₹ Crore
| Metric | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 108 | 54 | 51 |
| EBITDA | 9 | 5 | 1 |
| Profit After Tax | 5 | 2 | 0 |
| Net Worth | 32 | 1 | 5 |
| Total Assets | 57 | 33 | 33 |
| Reserves & Surplus | 18 | — | — |
| Total Borrowing | 22 | 30 | 26 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Funding of capital expenditure requirements of the company towards the construction of Pharmaceutical API/ Intermediates and Chemicals manufacturing plant and purchase of machineries in MIDC – Shrirampur, Ahmednagar, Maharashtra – 10.83
- Repayment/prepayment of all or certain of the borrowings availed of by the Company – 5.10
- General corporate purposes – 0.74
Company Overview
Incorporated in October 1971, Vijaypd Ceutical Limited distributes pharmaceutical products and consumer goods, offering a comprehensive range of services.
The company acts as representatives, dealers, agents, stockists, suppliers, traders, and packers.
The company serves the pharmaceutical and wellness industries, as well as the FMCG market, offering products like medicines (injections, tablets, capsules, ointments, suppositories, ophthalmic preparations, liquid oral products), vitamins, hormones, enzymes, wellness tonics, serums, diagnostic test kits, personal care items (soaps, sanitizers, baby care), ayurvedic products, cosmetics, food products, dental products, and crude drugs.
As of Marc 31, 2025, the company serves over r 2,109 pharmacies, clinics, and nursing homes across four districts, covering 20 locations.
The company's distribution network connects with over 170 healthcare product manufacturers, providing access to more than 19,000 SKUs.
This product portfolio allows the company to meet customer needs while ensuring quality and reliability in pharmaceutical supply.
The company is a pharmaceutical distributor with FDA, FSSAI, and BMC certifications.
Competitive Strength:
- Strengthen its market position by increasing its long-term relationships with its clients.
- Comprehensive product portfolio.
- Streamlined supply chain management.
- Experienced management team with proven execution capabilities.